KP Tissue Inc. Announces Quarterly Dividend for Shareholders
KP Tissue Inc. (KPT) has recently made an important announcement regarding its commitment to returning value to its shareholders. The Board of Directors has declared a quarterly dividend of $0.18 per common share. This dividend represents a significant component of the company's strategy to support its investors and enhance shareholder value.
Details of the Dividend Declaration
The dividend will be paid to shareholders of record on a specified date announced by the company. This payment reflects the ongoing positive performance of KP Tissue and its confidence in future growth and profitability. The declaration underscores the company’s dedication to providing consistent returns to investors.
Eligible Dividends Under Canadian Law
All dividends declared by KP Tissue are characterized as "eligible" dividends under the Income Tax Act of Canada and applicable provincial laws. This classification is essential for shareholders as it impacts how dividends are taxed, providing potential tax advantages for Canadian investors.
Dividend Reinvestment Plan Enhancements
KP Tissue offers a Dividend Reinvestment Plan (DRIP) allowing eligible shareholders to reinvest their cash dividends in additional common shares rather than receiving a cash payout. This plan enables shareholders to accumulate more shares over time, promoting long-term investment within the company.
Under the DRIP, the company automatically reinvests dividends, converting cash payouts into newly issued shares at prevailing market rates. This option can be appealing for investors looking to grow their investment without incurring additional transaction costs.
Participation Eligibility in the DRIP
Participation in the DRIP is specific to Canadian shareholders. Individuals interested in enrolling must contact their brokers or financial institutions to understand eligibility and any requirements to participate effectively. By taking advantage of the DRIP, shareholders can enhance their investment position in KPT.
Company Overview: KP Tissue Inc.
KP Tissue Inc. has a primary focus on acquiring and holding equity interests in Kruger Products, a reputable entity in the tissue manufacturing industry. The company controls a 12.5% interest in Kruger Products, signifying a strong partnership that supports its strategic business objectives.
For those interested in learning more about KP Tissue Inc., comprehensive details about their operations and shareholder initiatives are accessible through their official website.
Kruger Products: A Leader in Tissue Manufacturing
Kruger Products is recognized for its quality in the manufacturing of various tissue products. Its product range serves not only household needs but also industrial and commercial applications. With renowned brands that Canadian consumers trust, such as Cashmere and Purex, Kruger Products positions itself as a leader in the market.
Additionally, their U.S. operations include the production of the popular White Cloud brand, catering to a diverse customer base. Kruger Products continues to thrive with a dedicated workforce and numerous production facilities certified for sustainable practices.
Contact Information for Investor Inquiries
For any inquiries regarding the dividend and investment details, shareholders and interested parties can reach out to:
François Paroyan
General Counsel and Corporate Secretary
KP Tissue Inc.
905-812-6936
Email: francois.paroyan@krugerproducts.ca
Doris Grbic
Director, Investor Relations
KP Tissue Inc.
437-882-2596
Email: IR@krugerproducts.ca
Frequently Asked Questions
What is the amount of the declared dividend for KP Tissue Inc.?
The declared dividend is $0.18 per common share.
When will the dividends be paid?
The dividends are scheduled for payment on a specified date for shareholders on record prior to that date.
How does the Dividend Reinvestment Plan work?
Eligible shareholders can reinvest their cash dividends into additional shares of KP Tissue Inc. without incurring transaction costs.
Are all shareholders eligible for the DRIP?
No, only Canadian shareholders are eligible to participate in the Dividend Reinvestment Plan.
What is the primary business of KP Tissue Inc.?
KP Tissue Inc. focuses on acquiring and holding equity interests in Kruger Products, a leading tissue manufacturing company.
